ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Active Pharmaceutical Ingredients (API) Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-1W13849
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Veterinary Active Pharmaceutical Ingredients API Market Research Report 2023
BUY CHAPTERS

Global Veterinary Active Pharmaceutical Ingredients (API) Market Research Report 2025

Code: QYRE-Auto-1W13849
Report
May 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alivira Animal Health Ltd.
Qilu Pharmaceutical (Inner Mongolia) Co., Ltd.
Procyon Life Sciences
NGL Fine-Chem Ltd
Huvepharma
Jiangsu Lingyun Pharmaceutical Co. Ltd
Menadiona
SUANFARMAOfichem Group
Excel Veterinary HealthcareVetpharma(Insud Pharma)
lndukern Group
LasaSupergenerics Ltd.

Veterinary Active Pharmaceutical Ingredients (API) Market Size

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%.

Veterinary Active Pharmaceutical Ingredients (API) Market

Veterinary Active Pharmaceutical Ingredients (API) Market

The global market for Veterinary Active Pharmaceutical Ingredients (API) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Active Pharmaceutical Ingredients are the substances used in the fabrication of pharmaceutical drugs responsible for beneficial health effects produced by use of the product. An example of an API in veterinary medicine would be trimethoprim-sulfadoxine contained in the products Borgal, Trivetrin, or Trimidox.
The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 146%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Active Pharmaceutical Ingredients (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Active Pharmaceutical Ingredients (API).
The Veterinary Active Pharmaceutical Ingredients (API) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Active Pharmaceutical Ingredients (API) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Active Pharmaceutical Ingredients (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Veterinary Active Pharmaceutical Ingredients (API) Market Report

Report Metric Details
Report Name Veterinary Active Pharmaceutical Ingredients (API) Market
Accounted market size in 2022 $ 261 billion
Base Year 2022
Segment by Type
Segment by Application
  • CDMO
  • CMO
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Alivira Animal Health Ltd, Qilu Pharmaceutical (Inner Mongolia) Co, Ltd, Procyon Life Sciences, SUANFARMAOfichem Group, NGL Fine-Chem Ltd, Huvepharma, Jiangsu Lingyun Pharmaceutical Co. Ltd, Excel Veterinary HealthcareVetpharma(Insud Pharma), Menadiona, lndukern Group, LasaSupergenerics Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Veterinary Active Pharmaceutical Ingredients (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Veterinary Active Pharmaceutical Ingredients (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Veterinary Active Pharmaceutical Ingredients (API) Market report?

Ans: The main players in the Veterinary Active Pharmaceutical Ingredients (API) Market are Alivira Animal Health Ltd, Qilu Pharmaceutical (Inner Mongolia) Co, Ltd, Procyon Life Sciences, SUANFARMAOfichem Group, NGL Fine-Chem Ltd, Huvepharma, Jiangsu Lingyun Pharmaceutical Co. Ltd, Excel Veterinary HealthcareVetpharma(Insud Pharma), Menadiona, lndukern Group, LasaSupergenerics Ltd.

What are the Application segmentation covered in the Veterinary Active Pharmaceutical Ingredients (API) Market report?

Ans: The Applications covered in the Veterinary Active Pharmaceutical Ingredients (API) Market report are CDMO, CMO

What are the Type segmentation covered in the Veterinary Active Pharmaceutical Ingredients (API) Market report?

Ans: The Types covered in the Veterinary Active Pharmaceutical Ingredients (API) Market report are Chemical Based API, Biological API, Highly Potent APl(HPAPI)

Recommended Reports

Veterinary Diagnostics

Pet Pharmaceuticals

Animal Health Products

1 Veterinary Active Pharmaceutical Ingredients (API) Market Overview
1.1 Product Definition
1.2 Veterinary Active Pharmaceutical Ingredients (API) by Type
1.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Chemical Based API
1.2.3 Biological API
1.2.4 Highly Potent APl(HPAPI)
1.3 Veterinary Active Pharmaceutical Ingredients (API) by Application
1.3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Value by Application (2024 VS 2031)
1.3.2 CDMO
1.3.3 CMO
1.4 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size Estimates and Forecasts
1.4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue 2020-2031
1.4.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales 2020-2031
1.4.3 Global Veterinary Active Pharmaceutical Ingredients (API) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Veterinary Active Pharmaceutical Ingredients (API) Market Competition by Manufacturers
2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Veterinary Active Pharmaceutical Ingredients (API), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Product Type & Application
2.7 Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Date of Enter into This Industry
2.8 Global Veterinary Active Pharmaceutical Ingredients (API) Market Competitive Situation and Trends
2.8.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Veterinary Active Pharmaceutical Ingredients (API) Players Market Share by Revenue
2.8.3 Global Veterinary Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Active Pharmaceutical Ingredients (API) Market Scenario by Region
3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2020-2031
3.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2020-2025
3.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2026-2031
3.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2020-2031
3.3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2020-2025
3.3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2026-2031
3.4 North America Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
3.4.1 North America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2020-2031)
3.4.3 North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
3.5.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2020-2031)
3.5.3 Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2020-2031)
3.6.3 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
3.7.1 Latin America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2020-2031)
3.7.3 Latin America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2020-2031)
4.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2020-2025)
4.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2026-2031)
4.1.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2020-2031)
4.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2020-2031)
4.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2020-2025)
4.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2026-2031)
4.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2020-2031)
4.3 Global Veterinary Active Pharmaceutical Ingredients (API) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2020-2031)
5.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2020-2025)
5.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2026-2031)
5.1.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2020-2031)
5.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2020-2031)
5.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2020-2025)
5.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2026-2031)
5.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2020-2031)
5.3 Global Veterinary Active Pharmaceutical Ingredients (API) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Alivira Animal Health Ltd
6.1.1 Alivira Animal Health Ltd Company Information
6.1.2 Alivira Animal Health Ltd Description and Business Overview
6.1.3 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.1.5 Alivira Animal Health Ltd Recent Developments/Updates
6.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
6.2.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Information
6.2.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Description and Business Overview
6.2.3 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.2.5 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments/Updates
6.3 Procyon Life Sciences
6.3.1 Procyon Life Sciences Company Information
6.3.2 Procyon Life Sciences Description and Business Overview
6.3.3 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.3.5 Procyon Life Sciences Recent Developments/Updates
6.4 SUANFARMAOfichem Group
6.4.1 SUANFARMAOfichem Group Company Information
6.4.2 SUANFARMAOfichem Group Description and Business Overview
6.4.3 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.4.5 SUANFARMAOfichem Group Recent Developments/Updates
6.5 NGL Fine-Chem Ltd
6.5.1 NGL Fine-Chem Ltd Company Information
6.5.2 NGL Fine-Chem Ltd Description and Business Overview
6.5.3 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.5.5 NGL Fine-Chem Ltd Recent Developments/Updates
6.6 Huvepharma
6.6.1 Huvepharma Company Information
6.6.2 Huvepharma Description and Business Overview
6.6.3 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.6.5 Huvepharma Recent Developments/Updates
6.7 Jiangsu Lingyun Pharmaceutical Co. Ltd
6.7.1 Jiangsu Lingyun Pharmaceutical Co. Ltd Company Information
6.7.2 Jiangsu Lingyun Pharmaceutical Co. Ltd Description and Business Overview
6.7.3 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.7.5 Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments/Updates
6.8 Excel Veterinary HealthcareVetpharma(Insud Pharma)
6.8.1 Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Information
6.8.2 Excel Veterinary HealthcareVetpharma(Insud Pharma) Description and Business Overview
6.8.3 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.8.5 Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments/Updates
6.9 Menadiona
6.9.1 Menadiona Company Information
6.9.2 Menadiona Description and Business Overview
6.9.3 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.9.5 Menadiona Recent Developments/Updates
6.10 lndukern Group
6.10.1 lndukern Group Company Information
6.10.2 lndukern Group Description and Business Overview
6.10.3 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.10.5 lndukern Group Recent Developments/Updates
6.11 LasaSupergenerics Ltd.
6.11.1 LasaSupergenerics Ltd. Company Information
6.11.2 LasaSupergenerics Ltd. Description and Business Overview
6.11.3 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.11.5 LasaSupergenerics Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Active Pharmaceutical Ingredients (API) Industry Chain Analysis
7.2 Veterinary Active Pharmaceutical Ingredients (API) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Active Pharmaceutical Ingredients (API) Production Mode & Process Analysis
7.4 Veterinary Active Pharmaceutical Ingredients (API) Sales and Marketing
7.4.1 Veterinary Active Pharmaceutical Ingredients (API) Sales Channels
7.4.2 Veterinary Active Pharmaceutical Ingredients (API) Distributors
7.5 Veterinary Active Pharmaceutical Ingredients (API) Customer Analysis
8 Veterinary Active Pharmaceutical Ingredients (API) Market Dynamics
8.1 Veterinary Active Pharmaceutical Ingredients (API) Industry Trends
8.2 Veterinary Active Pharmaceutical Ingredients (API) Market Drivers
8.3 Veterinary Active Pharmaceutical Ingredients (API) Market Challenges
8.4 Veterinary Active Pharmaceutical Ingredients (API) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Alivira Animal Health Ltd.
Qilu Pharmaceutical (Inner Mongolia) Co., Ltd.
Procyon Life Sciences
NGL Fine-Chem Ltd
Huvepharma
Jiangsu Lingyun Pharmaceutical Co. Ltd
Menadiona
SUANFARMAOfichem Group
Excel Veterinary HealthcareVetpharma(Insud Pharma)
lndukern Group
LasaSupergenerics Ltd.
List of Tables
 Table 1. Global Veterinary Active Pharmaceutical Ingredients (API) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Veterinary Active Pharmaceutical Ingredients (API) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Veterinary Active Pharmaceutical Ingredients (API) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Veterinary Active Pharmaceutical Ingredients (API) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Veterinary Active Pharmaceutical Ingredients (API), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Product Type & Application
 Table 12. Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Veterinary Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Active Pharmaceutical Ingredients (API) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2020-2025)
 Table 19. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2026-2031)
 Table 21. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2020-2025)
 Table 23. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2026-2031)
 Table 25. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units) by Type (2020-2025)
 Table 51. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units) by Type (2026-2031)
 Table 52. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2020-2025)
 Table 53. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2026-2031)
 Table 54. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2020-2025)
 Table 57. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2026-2031)
 Table 58. Global Veterinary Active Pharmaceutical Ingredients (API) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Veterinary Active Pharmaceutical Ingredients (API) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units) by Application (2020-2025)
 Table 61. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units) by Application (2026-2031)
 Table 62. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2020-2025)
 Table 63. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2026-2031)
 Table 64. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2020-2025)
 Table 67. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2026-2031)
 Table 68. Global Veterinary Active Pharmaceutical Ingredients (API) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Veterinary Active Pharmaceutical Ingredients (API) Price (US$/Unit) by Application (2026-2031)
 Table 70. Alivira Animal Health Ltd Company Information
 Table 71. Alivira Animal Health Ltd Description and Business Overview
 Table 72. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product
 Table 74. Alivira Animal Health Ltd Recent Developments/Updates
 Table 75. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Information
 Table 76. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Description and Business Overview
 Table 77. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product
 Table 79. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments/Updates
 Table 80. Procyon Life Sciences Company Information
 Table 81. Procyon Life Sciences Description and Business Overview
 Table 82. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product
 Table 84. Procyon Life Sciences Recent Developments/Updates
 Table 85. SUANFARMAOfichem Group Company Information
 Table 86. SUANFARMAOfichem Group Description and Business Overview
 Table 87. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product
 Table 89. SUANFARMAOfichem Group Recent Developments/Updates
 Table 90. NGL Fine-Chem Ltd Company Information
 Table 91. NGL Fine-Chem Ltd Description and Business Overview
 Table 92. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product
 Table 94. NGL Fine-Chem Ltd Recent Developments/Updates
 Table 95. Huvepharma Company Information
 Table 96. Huvepharma Description and Business Overview
 Table 97. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product
 Table 99. Huvepharma Recent Developments/Updates
 Table 100. Jiangsu Lingyun Pharmaceutical Co. Ltd Company Information
 Table 101. Jiangsu Lingyun Pharmaceutical Co. Ltd Description and Business Overview
 Table 102. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product
 Table 104. Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments/Updates
 Table 105. Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Information
 Table 106. Excel Veterinary HealthcareVetpharma(Insud Pharma) Description and Business Overview
 Table 107. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product
 Table 109. Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments/Updates
 Table 110. Menadiona Company Information
 Table 111. Menadiona Description and Business Overview
 Table 112. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product
 Table 114. Menadiona Recent Developments/Updates
 Table 115. lndukern Group Company Information
 Table 116. lndukern Group Description and Business Overview
 Table 117. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product
 Table 119. lndukern Group Recent Developments/Updates
 Table 120. LasaSupergenerics Ltd. Company Information
 Table 121. LasaSupergenerics Ltd. Description and Business Overview
 Table 122. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product
 Table 124. LasaSupergenerics Ltd. Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Veterinary Active Pharmaceutical Ingredients (API) Distributors List
 Table 128. Veterinary Active Pharmaceutical Ingredients (API) Customers List
 Table 129. Veterinary Active Pharmaceutical Ingredients (API) Market Trends
 Table 130. Veterinary Active Pharmaceutical Ingredients (API) Market Drivers
 Table 131. Veterinary Active Pharmaceutical Ingredients (API) Market Challenges
 Table 132. Veterinary Active Pharmaceutical Ingredients (API) Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Veterinary Active Pharmaceutical Ingredients (API)
 Figure 2. Global Veterinary Active Pharmaceutical Ingredients (API) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Veterinary Active Pharmaceutical Ingredients (API) Market Share by Type: 2024 & 2031
 Figure 4. Chemical Based API Product Picture
 Figure 5. Biological API Product Picture
 Figure 6. Highly Potent APl(HPAPI) Product Picture
 Figure 7. Global Veterinary Active Pharmaceutical Ingredients (API) Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Veterinary Active Pharmaceutical Ingredients (API) Market Share by Application: 2024 & 2031
 Figure 9. CDMO
 Figure 10. CMO
 Figure 11. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (2020-2031) & (K Units)
 Figure 14. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price (US$/Unit) & (2020-2031)
 Figure 15. Veterinary Active Pharmaceutical Ingredients (API) Report Years Considered
 Figure 16. Veterinary Active Pharmaceutical Ingredients (API) Sales Share by Manufacturers in 2024
 Figure 17. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Veterinary Active Pharmaceutical Ingredients (API) Players: Market Share by Revenue in Veterinary Active Pharmaceutical Ingredients (API) in 2024
 Figure 19. Veterinary Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2020-2031)
 Figure 22. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2020-2031)
 Figure 23. United States Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2020-2031)
 Figure 26. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2020-2031)
 Figure 34. China Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Veterinary Active Pharmaceutical Ingredients (API) by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Veterinary Active Pharmaceutical Ingredients (API) by Type (2020-2031)
 Figure 53. Global Veterinary Active Pharmaceutical Ingredients (API) Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Veterinary Active Pharmaceutical Ingredients (API) by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Veterinary Active Pharmaceutical Ingredients (API) by Application (2020-2031)
 Figure 56. Global Veterinary Active Pharmaceutical Ingredients (API) Price (US$/Unit) by Application (2020-2031)
 Figure 57. Veterinary Active Pharmaceutical Ingredients (API) Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Veterinary API Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Active Pharmaceutical Ingredient API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Niche Active Pharmaceutical Ingredients API and Intermediates Market Research Report 2025
Veterinary APIs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Drug Premix Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2025
Sterile Dry Powder Active Pharmaceutical Ingredient API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Highly Potent Active Pharmaceutical Ingredients Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global NSAID API Market Research Report 2024
Global Nonsteroidal Anti inflammatory APIs Market Research Report 2024
Global Natural APIs Active Pharmaceutical Ingredients Market Research Report 2024
Active Pharmaceutical Ingredients API CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Pharmaceutical Preparations Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Supplements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Active Ingredient Formulation Analysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Functional Additives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Pharmaceuticals Market Research Report 2024
Antibiotics Active Pharmaceutical Ingredient Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Peptide Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions